Literature DB >> 832028

Monitoring adverse reactions to drugs.

C T Dollery, M D Rawlins.   

Abstract

Mesh:

Year:  1977        PMID: 832028      PMCID: PMC1604057          DOI: 10.1136/bmj.1.6053.96

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  20 in total

Review 1.  Pharmacovigilance in perspective.

Authors:  R H Meyboom; A C Egberts; F W Gribnau; Y A Hekster
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

2.  Hazards of non-practolol beta-blockers.

Authors: 
Journal:  Br Med J       Date:  1977-02-26

3.  Once is not enough.

Authors:  F Gross
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

4.  Monitoring adverse reactions to drugs.

Authors:  R Pearson
Journal:  Br Med J       Date:  1977-04-30

5.  Post-marketing surveillance or drug acceptability study?

Authors:  D B Barnett; K L Woods
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

Review 6.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  Can medical practice be free of risk?

Authors:  C Clarke
Journal:  J R Soc Med       Date:  1979-01       Impact factor: 5.344

8.  Post-marketing surveillance in the UK (1984).

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

9.  Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

10.  Cohort study of oestrogen treatment and the risk of endometrial cancer: evaluation of method and its applicability.

Authors:  I Persson; H O Adami; E Johansson; B Lindberg; P Manell; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.